Mark Montgomery

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities

Joanne Quan, Harm A.W.M. Tiddens, Judy P. Sy et al. · The Journal of Pediatrics · 2001 · 299 citations

Two-year Randomized, Pulmonary Care, Advanced Lung Disease +5

Reliability and predictive validity of contingent values: Does the nature of the good matter?

Mary Jo Kealy, Mark Montgomery, John F. Dovidio · Journal of Environmental Economics and Management · 1990 · 156 citations

Reliability, Behavioral Sciences, Predictive Validity +14

Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe

Thilo Dörk, Milan Maçek, Frauke Mekus et al. · Human Genetics · 2000 · 145 citations

Fibrosis, Mendelian Disorder, Genetic Disorder +11

Cardiopulmonary effects of closed repair of pectus excavatum

David L. Sigalet, Mark Montgomery, Joyce Harder · Journal of Pediatric Surgery · 2003 · 121 citations

Closed Repair, Pleural Effusion, Surgery +4

Obesity negatively impacts lung function in children and adolescents

Warren J. Davidson, Kelly A. Mackenzie‐Rife, Manisha Witmans et al. · Pediatric Pulmonology · 2013 · 118 citations